Home LiteratureArticle Details
PMID: 12749822 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Involvement of MEK/ERK pathway in cephaloridine-induced injury in rat renal cortical slices.

Toxicology letters ·Vol. 143 ·No. 2 ·2003-07-20 ·Pages 185-94

Kohda Y, Hiramatsu J, Gemba M

Abstract

We have previously reported that free radical-mediated injury induced by cephaloridine (CER) is enhanced by phorbol 12-myristate 13-acetate (PMA), a protein kinase C (PKC) activator, in rat renal cortical slices. We have also shown that PKC activation in mitochondria is involved in CER-induced nephrotoxicity in rats. We investigated the role of a downstream PKC pathway, a MEK/ERK pathway, in free radical-induced injury in rat renal cortical slices exposed to CER. Immediately after preparing slices from rat renal cortex, the slices were incubated in the medium containing MEK inhibitors. ERK1/2 activation was determined by Western blot analysis for phosphorylated ERK (pERK) 1/2 protein in nucleus fraction prepared from the slices exposed to CER. Prominently, CER caused not only increases in lipid peroxidation as an index of free radical generation and in LDH leakage as that of cell injury in the slices, but also marked activation of ERK1/2 in nucleus fraction. PD98059 and U0126, MEK1/2 inhibitors, significantly attenuated CER-induced increases in lipid peroxidation and LDH leakage in the slices. PD98059 also suppressed ERK1/2 activation in nucleus fraction prepared from the slices treated with CER. Inhibition of other MAP kinase pathways, p38 MAP kinase and c-Jun N-terminal kinase (JNK) had no effect on CER-induced increases in lipid peroxidation level and LDH leakage in the slices. The present results suggest that a MEK/ERK pathway down stream of a PKC pathway is probably involved in free radical-induced injury in rat renal cortical slices exposed to CER.

MeSH Terms
Animals Antioxidants/pharmacology Cephaloridine/pharmacology Enzyme Inhibitors/pharmacology Gene Expression Regulation In Vitro Techniques Kidney Cortex/drug effects,enzymology,metabolism,pathology MAP Kinase Signaling System/drug effects Male Mitogen-Activated Protein Kinase Kinases/antagonists & inhibitors,metabolism Mitogen-Activated Protein Kinases/antagonists & inhibitors,metabolism Phenylenediamines/pharmacology Phosphorylation Rats Rats, Sprague-Dawley
Chemicals
Antioxidants Enzyme Inhibitors Phenylenediamines N,N'-diphenyl-4-phenylenediamine Mitogen-Activated Protein Kinases Mitogen-Activated Protein Kinase Kinases Cephaloridine
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Kohda Yuka
Division of Pharmacology, Osaka University of Pharmaceutical Sciences, Nasahara, Takatsuki, 569-1094, Osaka, Japan. [email protected]
Hiramatsu Jun
Gemba Munekazu
Article Info
Journal
Toxicology letters
Abbr.
Toxicol Lett
ISSN
0378-4274
Published
2003-07-20
Pages
185-94
Language
English
Region
Netherlands
NLM ID
7709027
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]